Anesthesia and Pain Control Flashcards
Which of the following is correct regarding the use of naloxone for suspected opioid induced respiratory depression?
(A) The appropriate dose is 0.1- 0.4 mg IV q. 3-5 min
(B) It should be titrated in 1 mg increments IV q. 3-5 min until respiratory depression is
reversed
(C) The maximum recommended dose is 1.6 mg IV
(D) It should never be administered to a patient with a current history of opioid dependence
A
On a patient with known asthma, the use of fentanyl for sedation may produce:
(A) direct bronchoconstriction.
(B) reflex bronchoconstriction.
(C) release of vasoactive substances from mast cells.
(D) ventilatory depressant effects.
D
A submental intubation can be easily accomplished when a patient has been intubated with a: (A) nasal RAE tube. (B) wire-reinforced oral tube. (C) LMA. (D) standard oral endotracheal tube.
B
Which benzodiazepine has active metabolites that have clinical impact? (A) Triazolam (Halcion) (B) Midazolam (Versed) (C) Diazepam (Valium) (D) Oxazepam (Serax)
C
Oral midazolam in children:
(A) has a narrow toxic-therapeutic ratio.
(B) has a long onset of action.
(C) has a recommended dose of 0.5 mg/kg.
(D) is not recommended to be mixed in different carrying vehicles (juice, cola, and syrup) to
alleviate unpalatable taste.
C
Which medication given concomitantly would most effectively diminish the likelihood of ketamine emergence phenomena? (A) Fentanyl (B) Midazolam (C) Atropine (D) Esmolol
B
Propofol:
(A) is a sedative-hypnotic anesthetic agent.
(B) increases intracranial pressure.
(C) increases systemic vascular resistance.
(D) is a barbiturate anesthetic agent.
A
The use of intramuscular ketamine: (A) can cause significant pain on injection. (B) has a smooth but slow onset. (C) does not provide amnesia. (D) does have analgesic properties.
D
During intravenous sedation with propofol a possible complication is an increased risk of: (A) tachycardia following sedation. (B) hypotension during sedation. (C) prolonged sedation. (D) neutrophil dysfunction.
B
A 36 year-old female (ASA 1) loses consciousness prior to IV deep sedation. She is breathing, has a pulse rate of 84, and blood pressure of 63/34. Which of the following is appropriate treatment? (A) Atropine 2.0 mg IV (B) Ephedrine 10 mg IV (C) Epinephrine 0.1 mg IV q. 3–5 min (D) Nalaxone 0.4 mg IV
B
Which of the following is correct regarding the use of naloxone for suspected opioid induced respiratory depression?
(A) The appropriate dose is 0.1- 0.4 mg IV q. 3-5 min
(B) It should be titrated in 1 mg increments IV q. 3-5 min until respiratory depression is
reversed
(C) The maximum recommended dose is 1.6 mg IV
(D) It should never be administered to a patient with a current history of opioid dependence
A
On a patient with known asthma, the use of fentanyl for sedation may produce:
(A) direct bronchoconstriction.
(B) reflex bronchoconstriction.
(C) release of vasoactive substances from mast cells. (D) ventilatory depressant effects.
D
Which of the following statements is correct regarding the use of Propofol as an induction agent in a patient with asthma?
(A) Propofol will cause a relative broncho-constricting effect.
(B) The incidence of wheezing is higher with the use of Propofol than in patients receiving
Thiopental.
(C) Propofol is an appropriate agent for induction when subsequent tracheal intubation or
upper airway stimulation is anticipated.
(D) The generic form of Propofol (with metabisulfites) may be safer to use for induction.
C
Which of the following is true regarding the use of local anesthesia in children?
(A) The mandibular foramen is relatively higher and more anterior.
(B) The maximum recommended amount of lidocaine with or without vasoconstrictor is 9
mg/kg.
(C) Opioids can safely be administered because they will not lower the threshold for local
anesthetic toxicity.
(D) Local anesthetic toxicity in children typically manifests with seizures or CNS depression.
D
Oral midazolam in children:
(A) has a narrow toxic-therapeutic ratio.
(B) has a long onset of action.
(C) has a recommended dose of 0.5 mg/kg.
(D) is not recommended to be mixed in different carrying vehicles (juice, cola, and syrup) to
alleviate unpalatable taste.
C